Analyst Ratings for Strongbridge Biopharma (SBBP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/25/2021 | Craig-Hallum | Robin Garner | Downgrade | Hold (Buy) |
N/A (N/A) |
2.70 (2.00) |
-25.93% | Details |
| 5/25/2021 | Citizens | Liisa A. Bayko | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
2.41 (2.00) |
-17.01% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


